January 21, 2022 · STOCK Act disclosure
Representative Michael T. McCaul (Republican-TX) sold Neurocrine Biosciences, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on January 21, 2022 and was disclosed on January 27, 2022 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.